Need Pricey Drugs From An Obamacare Plan? You’ll Shoulder More Of The Cost
(By Jordan Rau and Julie Appleby and Elizabeth Lucas for Kaiser Health News) Substantially more health plans on the federal
Read More
Part D/Prescription Drugs
Rebates to pharmacy benefit managers are a hidden contributor to high drug prices
(By Douglas Hoey for ST A T) I n the furor over high drug prices, both Congress and the media
Read MoreA Frenzy Of Lobbying On 21st Century Cures
(By Sydney Lupkin for Kaiser Health News) The 21st Century Cures Act set for a House vote Wednesday is one
Read MoreCostco probed in Canada over alleged kickback scheme for generics
(By Ed Silverman for ST A T) A behind-the-scenes clash in Canada over generic competition has ensnared two Costco pharmacy
Read MoreDecember 7th Deadline is fast approaching
The deadline for Medicare open enrollment is December 7 th ; have you made your choice? If not, here are
Read MoreEli Lilly’s Alzheimer’s drug fails in late-stage trial, dashing hopes
(By Damian Garde for ST A T) A n investigational Alzheimer’s treatment from Eli Lilly failed to slow the progression
Read MoreTwo patient deaths halt trial of Juno’s new approach to treating cancer
(By Damian Garde and Meghana Keshavan for ST A T) I n a major blow to a new approach to
Read MoreHoping to attack opioid epidemic at its source, state Medicaid programs are limiting prescriptions
(By Shefali Luthra for Kaiser Health News published in partnership with ST A T) A s the abuse of prescription
Read MoreDrug side effects have led to increased ER visits in older Americans
(By Ed Silverman for ST A T) S ide effects from medication are causing more older Americans to visit emergency
Read MoreMylan refuses to testify at Senate hearing about EpiPen rebates to Medicaid
(By Ed Silverman for ST A T) I n a move that angered a key Senate lawmaker, Mylan Pharmaceuticals has
Read More